Thyroid cancer in children — what parents need to know
If your child has been found to have a thyroid nodule or has been diagnosed with thyroid cancer, you deserve a clear, honest explanation of what this means. Childhood thyroid cancer is uncommon — and it is also among the most treatable cancers in the paediatric age group when managed by a specialist multidisciplinary team. This page explains the types, the warning signs, how the diagnosis is made, and what treatment looks like for a child.
- Tumor board for every child — not one doctor’s opinion; a full multidisciplinary team including surgical and medical oncologists reviews each case
- 45-minute consultations — we answer every question fully; no rushed decisions on your child’s care plan
- Free first consultation — paediatric oncology assessment at no charge for first-time patients
- Transparent costs — written treatment plan and cost estimate before anything begins
on Panel
Survival Rate*
Treated
(800+ reviews)
Types of thyroid cancer in children — what every parent should know
The thyroid gland sits at the front of the neck and produces hormones that regulate growth, metabolism, and development — all critically important in a growing child. Thyroid cancer in children is not a single disease. The type your child has matters because the behaviour, the treatment approach, and the long-term monitoring differ between types.
Papillary Thyroid Cancer (PTC)
Papillary thyroid cancer is by far the most common type in children, accounting for the great majority of childhood thyroid cancer cases. It arises from the follicular cells of the thyroid — the cells responsible for making thyroid hormone. Despite being the most common type, papillary thyroid cancer is also generally the most responsive to treatment. It tends to grow slowly and, when detected, is often already managed well with surgery and, where needed, radioactive iodine therapy. Even when it has spread to nearby lymph nodes — which is more common in children than in adults — the overall outlook for well-treated papillary thyroid cancer in children is generally considered favourable. MEDICAL SIGN-OFF RECOMMENDED on outcome statements.
- May spread to neck lymph nodes, but this does not worsen outlook as it does in adults
- Treated primarily with thyroidectomy and, where indicated, radioactive iodine
- Lifelong thyroid hormone replacement required after total thyroidectomy
Follicular Thyroid Cancer (FTC)
Follicular thyroid cancer also arises from the follicular cells of the thyroid, but it behaves somewhat differently from papillary thyroid cancer. It is less likely to spread to lymph nodes but more likely to spread through the bloodstream to distant sites such as the lungs or bones — though distant spread at diagnosis is uncommon in children. One of the challenges with follicular thyroid cancer is that a fine-needle aspiration biopsy alone cannot always distinguish it from a benign follicular adenoma — this distinction often requires surgical removal and a careful review of the specimen by a specialist pathologist. Treatment is similar to papillary thyroid cancer: surgery followed by radioactive iodine where appropriate, and lifelong thyroid hormone replacement.
- FNAC alone may not confirm the diagnosis — surgery is often needed
- Less lymph node spread than PTC, but more attention to distant spread at staging
- Iodine uptake makes it responsive to radioactive iodine therapy in many cases
Medullary Thyroid Cancer (MTC)
Medullary thyroid cancer arises from the parafollicular C-cells of the thyroid rather than from follicular cells. C-cells produce calcitonin, a hormone involved in calcium regulation. A child diagnosed with medullary thyroid cancer should always be tested for inherited genetic syndromes — in particular MEN2A and MEN2B (multiple endocrine neoplasia) — because a significant proportion of medullary thyroid cancer cases, especially in children and adolescents, are hereditary. If a hereditary mutation is identified in the child, the family should be offered genetic counselling. Surgery is the main treatment for medullary thyroid cancer; radioactive iodine does not work for this type because C-cells do not take up iodine. Calcitonin levels are used as a tumour marker during follow-up.
- A significant proportion in children and adolescents is hereditary — genetic testing is essential
- Calcitonin is the key blood marker used to diagnose and monitor this type
- Radioactive iodine is not effective — surgery is the primary treatment
Poorly Differentiated & Other Rare Types
Anaplastic thyroid cancer is extremely rare in children and is primarily a disease of older adults. Poorly differentiated thyroid cancer — a category between well-differentiated and anaplastic — can occasionally occur in children, particularly in cases with a longer history of an untreated thyroid mass. Primary thyroid lymphoma is another rare possibility. Because these types are uncommon in the paediatric age group, they require specialist review at a multidisciplinary centre. If your child’s pathology report uses terms like “poorly differentiated” or “undifferentiated,” it is important to have the case reviewed by a team with experience in both paediatric oncology and thyroid cancers.
- Anaplastic thyroid cancer is extremely uncommon in children
- Specialist multidisciplinary review is essential for these rare subtypes
- Treatment approach is tailored to the specific type and extent of disease
Thyroid cancer is one of several cancers that affect children and adolescents. For a broader overview of paediatric cancer, visit the Pediatric Cancer hub. To learn about the warning signs that prompt further investigation in children, see Painless Lump or Swollen Lymph Node in a Child.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You deserve a clear answer — not more uncertainty
Our paediatric oncology team will review your child’s reports, explain what the diagnosis means in plain language, and walk you through every step of the treatment plan. Decisions for healing, not billing. No unnecessary tests.
How childhood thyroid cancer is diagnosed and treated — step by step
From the first neck ultrasound to long-term follow-up, here is what the care pathway looks like for a child with a thyroid nodule or thyroid cancer at CION. Every step is guided by a multidisciplinary tumor board, not a single doctor’s opinion.
Neck ultrasound — the first investigation
If a lump is found in your child’s neck or a thyroid nodule is suspected from a physical examination, the first step is a high-resolution neck ultrasound performed by a radiologist experienced in paediatric thyroid imaging. The ultrasound shows the size, location, and internal characteristics of any nodule — features such as solid composition, irregular margins, tiny calcifications, or abnormal lymph nodes nearby raise the level of concern and guide what happens next. Ultrasound alone does not diagnose cancer, but it tells the team whether further investigation is needed.
Blood tests — thyroid function and tumour markers
Alongside the ultrasound, the team will check your child’s thyroid function tests (TSH, T4) to understand how the thyroid is working, and will measure thyroglobulin — a protein produced by thyroid cells that can be elevated in certain thyroid cancers. For children where medullary thyroid cancer is suspected, calcitonin is measured as a specific marker. Genetic blood tests for hereditary syndromes (such as MEN2) may also be arranged at this stage if the clinical picture warrants it. These blood results help the team build a complete picture before deciding whether a biopsy is needed.
Fine-needle aspiration cytology (FNAC) — the biopsy
If the ultrasound shows features that raise concern, a fine-needle aspiration cytology (FNAC) is performed. A thin needle is guided into the nodule — typically under ultrasound guidance — and a small sample of cells is withdrawn for examination by a pathologist. In children, this is usually done under local anaesthesia or light sedation to keep the experience as calm as possible. The FNAC result is classified using a standard reporting system that helps the team decide between close monitoring and surgical intervention. In some cases, the result is “indeterminate” — meaning the cells cannot be definitively classified without surgical removal.
Tumor board review — before any recommendation is made
Before any treatment recommendation is made, the case is presented at a multidisciplinary tumor board at CION. This brings together the paediatric oncologist, surgical oncologist, radiologist, nuclear medicine specialist, and pathologist to review all of the evidence together — the child’s age, the ultrasound findings, the FNAC result, and the blood test results. The team agrees on the safest and most appropriate treatment plan as a group. You will receive a clear explanation of the recommended plan and the reasons for it during a 45-minute consultation. No rushed decisions.
Surgery — removing the thyroid gland
For most children with confirmed thyroid cancer, surgery is the primary treatment. The operation may involve removing the entire thyroid gland (total thyroidectomy) or, in select low-risk cases, only the affected lobe (hemithyroidectomy). The extent of surgery depends on the type of cancer, its size, and whether it has spread to nearby lymph nodes. In children, the surgery is performed by a surgical oncologist experienced in thyroid surgery and paediatric patients. Important nearby structures — including the parathyroid glands (which regulate calcium) and the nerves controlling the voice box — are carefully preserved. Your child will start on thyroid hormone replacement tablets (levothyroxine) promptly after the thyroid is removed.
Radioactive iodine (RAI) therapy — where indicated
After surgery, some children with papillary or follicular thyroid cancer are treated with radioactive iodine (RAI). This works because thyroid cells — both normal and cancerous — absorb iodine naturally. A therapeutic dose of radioactive iodine travels through the bloodstream and is taken up by any remaining thyroid tissue or cancer cells, destroying them from within. RAI is given as a capsule or liquid and is not painful. The child needs to stay in a special room for a day or two to allow the radioactivity to reduce to safe levels before going home. Not every child needs RAI — the tumor board determines whether the potential benefit outweighs the low risks. RAI does not work for medullary thyroid cancer.
Long-term follow-up — monitoring for life
Thyroid cancer in children requires careful long-term follow-up, even after successful treatment. This involves regular thyroglobulin blood tests (or calcitonin for medullary type) to detect any recurrence early, periodic neck ultrasounds to examine the surgical area and lymph nodes, and regular review of the levothyroxine dose as the child grows. The CION team will create a structured follow-up schedule for your child and explain what symptoms to watch for between appointments. Long-term follow-up after childhood thyroid cancer is not a sign that something is wrong — it is the standard of care that keeps the risk of recurrence as low as possible and catches any problem early when it is most treatable.
For a broader understanding of how cancers in children are diagnosed, see our page on How Childhood Cancer is Diagnosed.
Your child deserves the full picture — and a team that listens
Care led by a team, not a single doctor. 45-minute consultations where every question is answered. Transparent costs from the first visit.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Your questions about thyroid cancer in children — answered
Is thyroid cancer common in children?
What is a thyroid nodule in a child — should I be worried?
What are the warning signs of thyroid cancer in a child?
How is thyroid cancer in children diagnosed?
What is the treatment for thyroid cancer in a child?
Will my child need thyroid hormone tablets for life after treatment?
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.